Nirogy Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Nirogy Therapeutics's estimated annual revenue is currently $542.5k per year.
- Nirogy Therapeutics's estimated revenue per employee is $77,500
- Nirogy Therapeutics's total funding is $18.5M.
Employee Data
- Nirogy Therapeutics has 7 Employees.
- Nirogy Therapeutics grew their employee count by -53% last year.
Nirogy Therapeutics's People
| Name | Title | Email/Phone |
|---|
Nirogy Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Nirogy Therapeutics?
Nirogy Therapeutics is a biotechnology company based in Boston, MA developing novel small molecules to target cellular transporters. The company is currently advancing a class of small molecules intended to disrupt metabolic and immune mechanisms operative in the tumor microenvironment. Follow-on platform programs are targeting additional disease pathways in oncology as well as autoimmune diseases.
keywords:N/A
$18.5M
Total Funding
7
Number of Employees
$542.5k
Revenue (est)
-53%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Natick
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.1M | 7 | 17% | N/A |
#2 | $1.1M | 7 | -22% | N/A |
#3 | $1.1M | 7 | 40% | N/A |
#4 | $0.6M | 8 | 0% | N/A |
#5 | $0.6M | 8 | 14% | N/A |